Using this model, Sotalol (10 and SO@) 
Introduction
The ICH safety pharmacology guidance (S7B) 111 on QT interval prolongation by human pharmaceuticals specified in vitro methods for repolarization and conductance abnormalities as preclinical studies to identify adverse pharmacodynamic effects. The canine cardiac Purkinje fiber (CCPF) assay is a frequently used in vitro model, deriving action potential duration (APD) measurements using constant pacing stimulation. 
Biological background
The cells of Purkinje fibers are organized into several tracts that lead away from the atrioventricular node and ramify into the mass of ventricular tissue, distributing the electrical signal initiating contraction. From their termini the signal is spread through the working myocardium. Purkinje fiben are not nerves. but are actually modified strands of cardiac muscle that form nerve-like structures. Purkinje fibers are minimally contractile due to a paucity of actin and myosin fibrils. Purkinje fibers do' have some of the other features of cardiac myocytes, including a centrally located single nucleus. and even intercalated disks. All muscle tissue is "excitable" and this properly can be used to carry information [IO] . The canine cardiac rhythm is subject to a much greater variability compared to man due to a higher degree of responsiveness of the heart rate (RR cycle) to respiration [3]. The range of beat-to-beat changes the defining sinus arrhythmia is between 20 and 80 ms. while Beagle dogs operate in a range of 700 to loo0 ms (see Figure I ). I N=normd interval AP, =premature beat AP Premature beats are characterized by the lack of return to the resting potential, a reduced rate of depolarization and maximal depolarization amplitude, and a decreased APD (figures 2.3). If the coupling interval is sufficiently short (short RR interval), the AP shape is significantly a l t e d (as no full depolarization lakes place) and , :le followed by a very early premature beat. -sting potential CBDPSycle basic depolarization level CMDPSycle maximum depolarization level; thin arrows: depolarization gain;
Hypothesis
The constant frequency stimulation used in the standard CCPF model provides one established measure to evaluate drug effects on repolarization. An alternative approach presented here applies a stimulus protocol obtained from conscious animals, mimicking the strong sinus arrhythmia observed in dogs. The application of variable frequency stimulation in viiro may improve the sensitivity and predictivity of the CCPF model in detecting drug-induced changes of repolarization and proarrhythmic drug activity.
2.

Materials and methods
We investigated the effect of Sotalol (ascending concentrations of 10 and 50 ph4) on repolarization of cardiac Purkinje fibers in vitro using a) constant pacing rates (2000, 800 and 400 ms basic cycle lengths) and b) variable frequency pacing, with stimulation intervals obtained from telemetry-equipped Beagle dogs.
Materials
Protocols utilized to evaluate drug effects on the Purkinje fiber action potential duration have been described previously [12] . Briefly, larger, free-running canine cardiac Purkinje fibers were excised, placed in warmed (36.5-37.0 "C) chamber. and superfused (8-10 mldmin) with preheated Tyrode's solution containing (in mM): NaCI, 131; NaHC03, 18; NaH2P04, 1.8: MgCIZ, 0.5; dextrose, 5.5; KCl, 4: CaC12, 2 (aerated with 95% 0 2 / 5% C 0 2 [pH=7.2 at room temperature]). Fibers were field stimulated (2x threshold, biphasic waveform, typically 1-2 msec in duration) using platinum electrodes located in the chamber floor and impaled with 3M KCI-filled microelectrodes (resistance 10-30 M-ohm): electrical activity was monitored.
Equipment
Transmembrane potentials were obtained using high input impedance electrometers (IE-210, Warner Instruments). Signals were recorded digitally (typically 2 kHz, 16 bit resolution) using a Digidata 1200 hardware and Clamp 8 software (Axon Instruments) and analyzed using the proprietary ABBIOS software program [131.
Statistical calculations were performed on a personal computer using S+ (Insightful Inc.) and RSll (BBN Inc.).
Methods
Studies were initiated after a minimum 30-minute equilibration period with stimulation. Fibers were considered suitable for study if (during stimulation at 2 sec basic cycle length) the following criteria were satisfied a), the membrane potential just prior to action potential upstroke was more negative than -80 mV, b), the APD ranged between 300-500 msec (spanning approx. 1.2 standard deviations from the mean value of 405 msec), and c), the normal automatic rate did not exceed the 2 sec stimulation cycle length.
The depolarization gain (DG) was measured as difference between the peak of the action potential upstroke, named cycle maximum depolarization level (CMDP) and the resting potential (RF'). The action potential duration to x% of DG (APDx) is defined as the time when the repolarization transects the DG*(lWx) level.
We observed that standard programs use a definition of DG= (CMDP-CBDP)*(100-x), CBDP being the cycle basic depolarization level. This results in incorrect APDx estimates, with APDx falling too short.
Repolarization duration was measured at 30%. 50%.
70%, 90% and 95% of DG. We report only the usual 95% repolarization (APD95) in this work. In cases where the APD95 could not be measured due to prematurity, missing observations occurred. The DI was calculated as the time from APDPS to the subsequent stimulated upstroke [a]. The return curve (RC) (sometimes named restitution curves in literature) is defined as the relationship between DI of the preceding stimulation cycle and the subsequent APD95. RCs from variable frequency stimulation (obtained by plotting the diastolic interval vs. the APDx values of subsequent beats interval) were well fitted by: 1 Furthermore, loess-smoothing method was applied (weighting window 20% or 50% of observations) as a non-parametric method, and for control of fit by the logistic function. The first derivative of the fitted function, respectively consecutive differences of the loess-smoothed RC were used as an estimate of the slope, and the steepest slope is reported here. The slope of the RC may provide an indication of potential arrhythmogenicity.
A reasonable function estimate of return curves under constant BCL is not very reliable. Thus, we used the last IO BCL intervals at each BCL level for function fitting to ensure stable APD95 levels. The fitted function was:
APD95 = exp{const + b *log(DI -lag)}
A test with control treatment under constant pacing conditions at 2O00, 800 and 400 msec basic cycle length (BCL) was compared to variable frequency stimulation (Table 1) Three more experiments with other compounds (E3, E5 and E6) will be reported in another paper.
Results
For brevity we restrict our report to only the details of one experiment (E4). Due to protocols, constant and variable frequency pacing span different ranges of BCL (400 to 2MN) ms vs. 345-1275 ms). Though there are principally similar results in all three Sotalol experiments, we observed considerable interindividual differences in response on APDDI slopes.
Constant frequency pacing
Under conml conditions, step changes in pacing frequency (from Zoo0 to 800 msec and from 800 to 400 msec basic cycle length) elicited an exponential adoption function of APD90 that required greater than 1 minute for stabilization to a constant level (Figure 4) . In one of four fibers we observed chaotic response after suddenly shortening the BCL from 800 to 4OOms during exposure to 50 pM Sotalol (Figure 4) . The same preparation showed chaotic response to the dynamic Treatments from bottom to top: CON, SOTIO, SOTSO.
Variable frequency pacing
An example of a rate transformed return curve of variable frequency pacing is shown in figure 6 . A clear separation is seen between the RCs with the slopes and APD95-distances differ considerably. 
Discussion and Conclusions
Sotalol elicited a dose-dependent shift of the variable frequency pacing return curve in a dose dependent manner towards increased APDs and lower DI. 50pM Sotalol significantly decreased the diastolic interval. The increased slopes of the return curve with the high Sotalol concentration represent increased electrophysiologic instability.
Further investigations are necessary to assess the utility of the variable pacing protocol and electrophysiologic ' instability in vitro as a surrogate marker for proarrhythmia in the CCPF model.
